🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Centene Corporation CNC SPX

Healthcare · Healthcare Plans · United States
https://www.centene.com
Company Profile ↓
$66.61
+117.40% 1Y
Mkt Cap$32.89B
P/E-5.07
P/B1.58
52W High$68.72
52W Low$25.21
Book Value$43.40
EPS (TTM)$-13.13

Company Overview

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 26.2% CAGR over the past five years.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $174.58B (+20.0% YoY); net profit $-6.67B.
  • Trailing 12 Months Year-on-year growth — revenue +5.1%, earnings +18.3%.
  • 5-Year Trend Long-term compounding — revenue CAGR 26.2%.

Growth & Price Performance

Compounded Sales Growth

5 Years:26.15%
1 Year:5.10%

Compounded Profit Growth

5 Years:-
1 Year:18.30%

Stock Price Performance

1 Year:+117.40%
6 Months:+43.59%
3 Months:+78.77%
1 Month:+2.18%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 95% of range
$25.21 $68.72
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)56.72 · Neutral
Price Performance
1M+2.18%
3M+78.77%
6M+43.59%
1Y+117.40%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 26.2% over 5 years.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-5.07
Industry PE
25.88
Forward P/E
14.88
PEG Ratio
1.30
Book Value
$43.40
Price to Book
1.58
P/S
0.19
EV/EBITDA
9.18
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
26.15%
Profit 5Y
-
Revenue (YoY)
5.10%
Earnings (YoY)
18.30%

Profitability & Returns

ROCE
-19.03%
ROE
-26.04%
ROA
1.22%
Profit Margin
-3.61%
Op Margin
5.07%
Gross Margin
10.56%
EPS (Latest Qtr)
$3.11
EPS (TTM)
$-13.13

Balance Sheet & Liquidity

Debt/Equity
0.76
Quick Ratio
1.08
Current Ratio
1.12
Debt
$16.37B
Total Assets
$81.17B
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
0.39%
Chg in Prom Hold
-
FII / Inst Holding
100.58%
Chg in FII Hold
-0.10%

Financial Snapshot

Enterprise Value
$32.89B
Total Revenue (TTM)
$178.33B
EBITDA
$2.90B
Free Cash Flow
$6.85B
Operating Cash Flow
$7.94B
Shares Outstanding
493.80M
Gross Margin
10.56%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 CNC Centene Corporation SPX 66.61 -5.07 $32.89B 0.00% -19.03% -26.04% 26.15% -
2 LLY Eli Lilly and Company SPX 1,156.63 41.13 $1.03T 0.60% - 107.46% 7.20% 11.41%
3 JNJ Johnson & Johnson SPX 247.02 28.66 $594.63B 2.23% 14.88% 26.42% 2.43% 4.76%
4 ABBV AbbVie Inc. SPX 244.11 119.08 $431.29B 3.04% 10.47% -129.24% 1.75% -29.06%
5 UNH UnitedHealth Group Incorporated SPX 418.52 31.54 $380.08B 2.18% 9.74% 12.18% 10.40% 5.43%
6 MRK Merck & Co., Inc. SPX 123.61 34.82 $305.29B 2.82% - 18.94% 5.64% 10.01%
7 AZN AstraZeneca PLC NDX 168.37 26.10 $261.12B 1.87% 15.97% 23.48% 9.82% 45.96%
8 TMO Thermo Fisher Scientific Inc. SPX 535.29 29.40 $198.93B 0.35% 8.14% 13.52% 8.81% 12.95%
9 AMGN Amgen Inc. NDXSPX 358.32 24.92 $193.39B 2.80% 18.02% 101.32% 11.77% 5.58%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026
Revenue ----------11.44B11.42B-12.56B12.88B15.36B-16.84B17.30B18.21B-24.17B25.72B27.46B28.11B28.86B30.51B34.23B33.97B33.73B34.95B34.84B34.97B36.34B35.97B36.90B42.49B42.47B44.90B44.66B
Gross Profit ---------------------------4.41B4.56B4.04B4.65B4.61B4.63B4.74B4.53B4.01B5.29B3.02B3.35B5.65B
Operating Income -129.00M173.00M183.00M-20.00M377.00M342.00M-240.00M438.00M340.00M-540.00M489.00M41.00M-685.00M643.00M176.00M-188.00M2.02B861.00M1.05B-418.00M545.00M1.25B-129.00M476.00M1.22B1.17B735.00M1.11B1.23B665.00M1.53B-458.00M-6.95B1.86B
Net Income 107.00M63.00M88.00M93.00M111.00M-16.00M170.00M147.00M261.00M139.00M254.00M205.00M230.00M340.00M300.00M19.00M241.00M522.00M495.00M95.00M209.00M46.00M1.21B568.00M699.00M-535.00M584.00M849.00M-172.00M738.00M1.13B1.06B469.00M1.16B1.15B713.00M1.31B-253.00M-6.63B1.54B
Diluted EPS 0.880.510.720.760.90-0.130.970.841.490.390.720.580.650.960.750.050.571.241.180.230.490.082.050.971.19-0.920.991.44-0.291.272.041.920.872.162.161.362.63-0.51-13.503.11

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 3.36B4.10B4.45B5.21B8.11B10.86B16.56B22.76B37.58B45.62B56.44B70.36B103.80B117.98B135.48B140.09B145.50B174.58B
Gross Profit -------------14.49B16.92B17.64B17.07B14.21B
Operating Income 131.56M138.13M157.07M203.80M108.00M277.00M464.00M705.00M1.26B1.20B1.46B1.78B3.08B1.78B1.32B2.93B3.17B-7.62B
Net Income 83.50M83.67M94.84M111.22M2.00M165.00M271.00M355.00M562.00M828.00M900.00M1.32B1.81B1.35B1.20B2.70B3.31B-6.67B
Diluted EPS 1.881.891.882.120.021.472.252.881.712.342.263.143.122.282.074.956.31-13.53

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --1.70B1.94B2.19B2.77B3.52B5.82B7.34B20.20B21.86B30.90B40.99B68.72B78.38B76.87B84.64B82.44B76.75B
Total Equity 415.05M501.27M600.85M793.94M935.63M953.06M1.23B1.74B2.16B5.89B6.85B10.92B12.55B25.77B26.80B24.06B25.84B26.41B19.95B
Cash & Equivalents 268.58M379.10M403.75M434.17M573.70M745.93M974.00M1.61B1.76B3.93B4.07B5.34B12.12B10.80B13.12B12.07B17.19B14.06B17.89B
Long Term Debt --307.08M327.82M348.34M535.48M666.00M874.00M1.22B4.65B4.70B6.65B13.64B16.68B18.57B17.94B17.71B18.42B17.35B
Total Liabilities --1.08B1.15B1.25B1.82B2.29B3.93B5.01B14.14B14.98B19.88B28.30B42.76B51.35B52.63B58.69B55.94B56.69B
Current Liabilities --715.91M765.25M837.61M1.23B1.56B2.90B3.63B8.62B9.33B11.97B12.93B21.59B25.77B28.46B36.72B34.26B36.70B

Cash Flows (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 221.98M248.19M168.93M261.70M279.00M382.00M1.22B658.00M1.85B1.49B1.23B1.48B5.50B4.21B6.26B8.05B154.00M5.09B
Investing Cash Flow -153.92M-270.09M-210.61M-129.08M-188.00M-342.00M-848.00M-813.00M-2.47B-1.25B-4.58B-1.53B-6.96B-3.30B-2.92B-1.19B-1.05B472.00M
Financing Cash Flow 42.46M46.55M72.09M6.91M179.00M154.00M198.00M305.00M2.72B-82.00M4.61B6.83B260.00M1.36B-4.20B-1.66B-2.41B-1.62B
Capital Expenditure -65.16M-23.72M-118.56M-73.71M-82.00M-68.00M-103.00M-150.00M-306.00M-422.00M-675.00M-730.00M-869.00M-910.00M-1.00B-799.00M-644.00M-767.00M
Free Cash Flow 156.82M224.47M50.38M187.99M197.00M314.00M1.12B508.00M1.54B1.07B559.00M753.00M4.63B3.29B5.26B7.25B-490.00M4.32B
Share Buybacks 23.51M6.30M3.22M7.81M13.00M19.00M29.00M53.00M63.00M65.00M71.00M75.00M626.00M297.00M3.10B1.63B3.12B475.00M

Ratios (Annual)

Figures in %.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -------------12.3%12.5%12.6%11.7%8.1%
Operating Margin % 3.9%3.4%3.5%3.9%1.3%2.5%2.8%3.1%3.4%2.6%2.6%2.5%3.0%1.5%1.0%2.1%2.2%-4.4%
Net Margin % 2.5%2.0%2.1%2.1%0.0%1.5%1.6%1.6%1.5%1.8%1.6%1.9%1.7%1.1%0.9%1.9%2.3%-3.8%
ROE % 16.7%13.9%11.9%11.9%0.2%13.4%15.5%16.5%9.5%12.1%8.2%10.5%7.0%5.0%5.0%10.5%12.5%-33.4%
ROCE % -14.0%13.3%15.1%7.0%14.1%15.9%19.0%10.9%9.6%7.7%6.3%6.5%3.4%2.7%6.1%6.6%-19.0%

Shareholding Pattern

Insiders
0.39%
Institutions
100.58%
Public Float
100.98%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 8.06% 39.82M $2.74B
2 AQR Capital Management, LLC 6.81% 33.61M $2.31B
3 Vanguard Capital Management LLC 6.33% 31.23M $2.15B
4 Vanguard Portfolio Management LLC 4.38% 21.63M $1.49B
5 State Street Corporation 4.38% 21.65M $1.49B
6 Harris Associates L.P. 2.85% 14.09M $968.58M
7 Geode Capital Management, LLC 2.63% 12.99M $892.50M
8 Invesco Ltd. 2.15% 10.62M $729.54M
9 Ameriprise Financial, Inc. 2.05% 10.13M $696.01M
10 Morgan Stanley 2.00% 9.88M $678.97M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for CNC

Google News Wed, 15 Jul 2026

Fund Update: New $8.1M $CNC stock position opened by Prospera Financial Services Inc - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxOUVR3SkhSZnNUSG45VGtWZFNRMXdoZUVZMXk1TE11RnViSDdjQWVuNm13b2tiUTlUZUY1MGZKQW4yNVZyNno4SzlHa1JwUnJWaXI4RkhhN3g0c09PTXdGSFdCNFc2R3FuTU9NNE5ueHNrYUx5RmlRa3pJNkdvWWxuSDJtUkdsYjhsWHJyTV…

Google News ue, 14 Jul 2026

symbol__ Stock Quote Price and Forecast - CNN

<a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE52WWFuZW80X1N5Vnh3dnZxN19HNzlTZkxkS2xmMnpTVkJCc1FMUUozOFE4Zmd1MkFiOW9WalNvLUhtNVZOaEwyS0k3YTlXaTQ?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a>&nbsp;&nbsp;<font…

Google News Sat, 11 Jul 2026

Centene (CNC) Stock May Still Be A Bargain After A 114% Run - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxPT0x1c2kwbWVrZ1NPbFRob05kOUtKd0hqRHVpeWw5VUFzdUl2UFNVY2xlV1c1MzFhZXVYWTZOZUwzTlBmOV9NQUwtVTVTck1GRF9YRVB1eXlVS21Ld1FIZElpYkJXc2FYbzdwekJZVGJDXzY2czlVUHdudEJYODBrcWhNaHlGUzZocy1RNj…

Google News Wed, 15 Jul 2026

Is Centene Corp (CNC) a Bargain After 3.1% Drop? GF Value Says Undervalued - GuruFocus

<a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE02NWVmSHJMRzJaQ1pzdHVfaHowZFhILS02YkNRbEc0Qkk1UmQyRm1iblFaOHQzWkZSeGxtQ1JLZGo0Z2pIcjFXUktqNm11TDg?oc=5" target="_blank">Is Centene Corp (CNC) a Bargain After 3.1% Drop? GF Value Sa…

Google News ue, 14 Jul 2026

1 Large-Cap Stock with Exciting Potential and 2 We Turn Down - StockStory

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxQWXBrMVpFSnJBbWc2cGNja1M5dTl5MTd0a1JNT0RfRXAyOUNZaHFlRmloWVdfT21Yc1BYU0hQc1ZDX1dqbTdhSEx2bGhWUE53d09JSHZ2eVR3QWJGdXREN2FJcTQzaDZDUzN4Vzd3QTAwaFBlSHEwNjZrQTYyX2k3ZjRuWUhRQzBDNzEtZm…

Google News Sat, 11 Jul 2026

CNC News | CENTENE CORP (NYSE:CNC) - ChartMill

<a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE5OcEFHZXBmdGZSMUt5WnlUS1prNURLMUNLT0VLWmNOMjR1Ny1oZUVOOHk2WW4yN0hJMGlvZ1JGVVNXYmlvZnFJVFk1eGVaUkZVXzZZU1U4M0k2Zw?oc=5" target="_blank">CNC News | CENTENE CORP (NYSE:CNC)</a>&nbsp;&…

CNC — Frequently Asked Questions

What is the current share price of Centene Corporation (CNC)?

As of 2026-07-15 16:51 PDT, Centene Corporation (CNC) trades at $66.61 on NYSE. Its 52-week range is $25.21 to $68.72.

What is the market capitalisation of CNC?

Centene Corporation (CNC) has a market capitalisation of $32.89B on NYSE.

What is the P/E ratio of CNC?

CNC trades at a trailing price-to-earnings (P/E) ratio of -5.07. The industry average P/E is 25.88. Its price-to-book (P/B) ratio is 1.58.

What is the return on equity (ROE) of CNC?

CNC has a return on equity (ROE) of -26.04%. Its return on capital employed (ROCE) is -19.03%.

Is CNC a good stock to buy?

This page provides a data-driven analysis of Centene Corporation (CNC), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space